Too much water drowned the miller: Akkermansia determines immunotherapy responses.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35584634.
- Also identified by DOI 10.1016/j.xcrm.2022.100642 and PMC identifier 9133437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Derosa et al.<sup>1</sup> demonstrated that intestinal Akkermansia muciniphila predicts vigorous response to immunotherapy in non-small-cell lung cancer. Baseline level of this microbe has better value than PD-L1 expression and represents a unique approach for stratifying patients that can benefit from immunotherapy.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms